'From' July 2012, new European wide legislation comes into effect whereby PharmaBio organizations that hold marketing authorizations for products in Europe will need to electronically report both serious and non-serious adverse reactions to one central point—EudraVigilance, the safety database of the European Medicines Agency (EMA), based in London. This is a major change, and requires organizations that carry out Pharmacovigilance to...
Read More
Monthly Archives: April 2012
As a follow-up to my posting on the impact of Patents on eClinical solutions, here is a list of patents relevant to the article; With each patent, I have placed…
We are glad to announce the arrival of Ian Mills into the eClinicalHealth expert team. Ian, an advanced hands on programming expert, has lead the development of a number of…
(Update: See also the follow-up post – a List of eClinical Patents) The Patent system was designed to protect individuals and companies from others that might steal their ideas. If…